ASX Company Announcements


The edited text of our announcements are sourced from the Australian Stock Exchange and are delayed by at least 20 minutes. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.

Cellmid does not take any responsibility in respect of any of the edited text sourced from the Australian Stock Exchange

  

18 Dec 2014

 Cleansing Notice and Appendix 3B

15 Dec 2014

 Key Midkine Antibody Patent Granted

15 Dec 2014

 Cellmid Capital Raising

11 Dec 2014

 Trading Halt

17 Nov 2014

 Cellmid Signs Agreement with Zoetis

29 Oct 2014

 Appendix 4C - quarterly

10 Oct 2014

 Results of Meeting

10 Oct 2014

 AGM Presentation by CEO

16 Sep 2014

 Cellmid 2014 Annual Report to Shareholders

 29 Aug 2014

 Appendix 4E and Preliminary Final Report

 18 Aug 2014

 Cellmid News

 29 Jul 2014

 Appendix 4C - quarterly

 16 Jul 2014

 Cellmid Granted UK Patent for Use of Midkine for Hair Growth

 15 Jul 2014

 Landmark Study - FGF5 Critical Regulator of Human Hair Growth

 20 Jun 2014

 Quest Diagnostic License Update

 19 Jun 2014

 Manufacturing Partner Appointed by Cellmid

 02 Jun 2014

 Change of Director's Interest Notice - Graeme Kaufman 

 20 May 2014

 Notice of ceasing to be a substantial holder

 07 May 2014

 Key Milestone Completed: Cellmid Lead Antibody Selected for Clinical Trials

 30 Apr 2014

 Significant New Findings Presented at 3rd Midkine Symposium in Kyoto

 28 Apr 2014

 Appendix 4C - quarterly

 22 Apr 2014

 Release of Shares from Voluntary Escrow

 15 Apr 2014

 Cellmid Signs Mk Tribody Collaboration Agreement

 31 Mar 2014

 Presentation to the Market

 24 Mar 2014

 Cellmid News

 27 Feb 2014

 Appendix 4D and Half Year Report

 17 Feb 2014

 Cleansing Notice and Appendix 3B

 10 Feb 2014

 USA RNA/DNA Patent for Surgical Adhesion Allowed

 29 Jan 2014

 Chinese Distribution Agreement Signed for Hair Loss Products

 28 Jan 2014

 Appendix 4C - quarterly

 06 Jan 2014

 Change of Director's Interest Notice - Maria Halasz